Bearsville New York based BAKX Therapeutics is raising $34,255,728.00 in New Equity Investment.
Bearsville, NY – According to filings with the U.S. Securities and Exchange Commission, BAKX Therapeutics is raising $34,255,728.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Sree Kant played a…